Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN21955180
ISRCTN21955180
Completed
未知

A double-blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron

The Medical Research Council (MRC) (UK)0 sites498 target enrollmentApril 14, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAnaemia in pregnancyPregnancy and Childbirth

Overview

Phase
未知
Intervention
Not specified
Conditions
Anaemia in pregnancy
Sponsor
The Medical Research Council (MRC) (UK)
Enrollment
498
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

  1. 2016 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/27411564 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31607468 (added 15/10/2019)
Registry
who.int
Start Date
April 14, 2014
End Date
March 21, 2015
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
The Medical Research Council (MRC) (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Pregnant (gestational age between 14 \- 22 weeks)
  • •2\. Age: 18 to 45 years
  • •3\. Likely to be resident in study area for duration of trial
  • •4\. Written informed consent obtained

Exclusion Criteria

  • •1\. Severely anaemic (\< 7 g/dl)
  • •2\. Seriously ill (infectious disease of clinical significance) at recruitment
  • •3\. Chronic disease
  • •4\. Pregnancy complications (e.g. pre\-eclampsia) at enrolment
  • •5\. Already part of another study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Rituximab versus cyclophosphamide in connective tissue disease-ILDInterstitial lung disease in people with severe connective tissue disease, including systemic sclerosis, idiopathic interstitial myopathy (including polymyositis/dermatomyositis) and mixed connective tissue diseaseRespiratory
ISRCTN16474148Royal Brompton & Harefield NHS trust104
Completed
Not Applicable
Mirtazapine for treatment resistant depressio
ISRCTN06653773niversity of Bristol (UK)400
Completed
Not Applicable
Gentamicin in the treatment of Gonorrhoea (G-TOG)
ISRCTN51783227niversity Hospital Birmingham NHS Foundation Trust (UK)720
Completed
Phase 2
Investigating the effects of dietary nitrate in patients with stable anginaTopic: Cardiovascular diseaseSubtopic: Cardiovascular (all Subtopics)Disease: Cardiovascular PreventionCirculatory SystemCardiovascular disease prevention
ISRCTN17373946Queen Mary University of London246
Completed
Not Applicable
A randomised controlled trial to compare two different platelet count thresholds for prophylactic platelet transfusion to preterm neonates
ISRCTN87736839ational Blood Service (UK)660